Antenatal Receipt of Sulfadoxine-Pyrimethamine Does Not Exacerbate Pregnancy-Associated Malaria Despite the Expansion of Drug-Resistant Plasmodium falciparum: Clinical Outcomes From the QuEERPAM Study
Steve M Taylor, Alejandro L Antonia, Ebbie Chaluluka, Victor Mwapasa, Gaoqian Feng, Malcolm E Molyneux, Feiko O ter Kuile, Steven R Meshnick, Stephen J Rogerson
Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2012
Awarded by National Institutes of Health (NIH)
Awarded by NIH-Fogarty International Center
This work was supported by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine (to F. O. tK.). Sample collection was funded by a Career Development Fellowship and a Senior Overseas Biomedical Research Fellowship awarded by the Wellcome Trust (to S. J. R.) and by grants from the National Institutes of Health (NIH; AI 49084), NIH-Fogarty International Center (5 D43 TW00908), and the Center for AIDS Research at the University of North Carolina (to S. R. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.